Source: Annual Congress 2010 - High-priority questions on airway infections in diseases seen in children and adults
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Smyth (Notthingham, United Kingdom). Treatment strategies for cystic fibrosis: what's in the pipeline?. Annual Congress 2010 - High-priority questions on airway infections in diseases seen in children and adults

Member's Comments

No comment yet.

Related content which might interest you: Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next? Source: International Congress 2018 – Therapeutic breakthroughs Year in Review Year: 2018 End-stage cystic fibrosis: what to measure and what to try? Source: Annual Congress 2011 - End-stage lung disease in children Year: 2011 What’s new in cystic fibrosis? Source: International Congress 2018 – Paediatric Year in Review Year: 2018 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Is newborn screening for cystic fibrosis cost-effective? Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010 Re-imagining cystic fibrosis care: next generation thinking Source: Eur Respir J, 55 (5) 1902443; 10.1183/13993003.02443-2019 Year: 2020 Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise? Source: Eur Respir J 2007; 29: 229-230 Year: 2007 What's it like to live with idiopathic pulmonary fibrosis? Ask the experts Source: Eur Respir J 2016; 47:1324-1326 Year: 2016 Modelling and simulation of experimental designs to find the best design of randomized clinical trials in a rare disease: Cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Idiopathic pulmonary fibrosis: time for greater expectations? Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018 Year: 2018 Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash? Source: Eur Respir J 2011; 37: 757-759 Year: 2011 Does this patient have cystic fibrosis?  Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session Year: 2017 Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard Source: Eur Respir J 2015; 45: 1208-1210 Year: 2015 Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes Source: Eur Respir J 2013; 42: 1155 Year: 2013 Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes Source: Eur Respir J 2013; 42: 1156-1157 Year: 2013 Cystic fibrosis: prospects for therapy of some class 1 mutations Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver? Year: 2007